Reduction of Daunorubicin in A549 Cells: The Role of Carbonyl Reductases 1

Different NADPH-dependent oxidoreductases, namely AKR1A1, AKR1B10, AKR1C3, and CBR1, are responsible for daunorubicin metabolism and are thus involved in chemoresistance. Here, we used thiazolidinone derivatives as inhibitors of these enzymes in order to define daunorubicin detoxification in the lung carcinoma A549 cell line, in which the four enzymes are all expressed. The evaluation of the effect of different inhibitors on both daunorubicin transformation in cell extracts and daunorubicin toxicity in cultured cells supports a prominent contribution of CBR1 to daunorubicin reduction in A549 cells. A combined treatment of A549 cells with daunorubicin and the most promising compound among those tested induced both significant cytotoxicity, which occurred through an increase in the apoptotic rate, and a complete impairment of clonogenic survival. These results suggest CBR1 as a potential target to impair daunorubicin metabolism in A549 cells.

Authors

Institutions

Publication Details

Journal
Biology
Published
2026-11-12
DOI
https://doi.org/10.3390/biology15222071
Primary Topic
Bioactive Compounds and Antitumor Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Reduction of Daunorubicin in A549 Cells: The Role of Carbonyl Reductases 1

Roberta Moschini, Gemma Sardelli, Giovanni Signore, Rosanna Maccari et al.
Biology
Bioactive Compounds and Antitumor Agents
article

Reduction of Daunorubicin in A549 Cells: The Role of Carbonyl Reductases 1

Roberta Moschini, Gemma Sardelli, Giovanni Signore, Rosanna Maccari, Antonella Del Corso, Francesca Felice, Rosaria Ottanà, Martina Avanatti
article en

Abstract

Different NADPH-dependent oxidoreductases, namely AKR1A1, AKR1B10, AKR1C3, and CBR1, are responsible for daunorubicin metabolism and are thus involved in chemoresistance. Here, we used thiazolidinone derivatives as inhibitors of these enzymes in order to define daunorubicin detoxification in the lung carcinoma A549 cell line, in which the four enzymes are all expressed. The evaluation of the effect of different inhibitors on both daunorubicin transformation in cell extracts and daunorubicin toxicity in cultured cells supports a prominent contribution of CBR1 to daunorubicin reduction in A549 cells. A combined treatment of A549 cells with daunorubicin and the most promising compound among those tested induced both significant cytotoxicity, which occurred through an increase in the apoptotic rate, and a complete impairment of clonogenic survival. These results suggest CBR1 as a potential target to impair daunorubicin metabolism in A549 cells.

BiologyVol. 15(22)
University of Pisa (IT), University of Messina (IT)
Good health and well-being
Bioactive Compounds and Antitumor Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon